butrin has been researched along with calcimycin in 1 studies
Studies (butrin) | Trials (butrin) | Recent Studies (post-2010) (butrin) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
---|---|---|---|---|---|
6 | 0 | 3 | 11,946 | 40 | 444 |
Protein | Taxonomy | butrin (IC50) | calcimycin (IC50) |
---|---|---|---|
XBP1 | Homo sapiens (human) | 1.41 | |
DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akhtar, N; Haqqi, TM; Khan, A; Khan, KA; Rasheed, Z | 1 |
1 other study(ies) available for butrin and calcimycin
Article | Year |
---|---|
Butrin, isobutrin, and butein from medicinal plant Butea monosperma selectively inhibit nuclear factor-kappaB in activated human mast cells: suppression of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8.
Topics: Butea; Calcimycin; Chalcones; Chromatography, Thin Layer; Enzyme-Linked Immunosorbent Assay; Flavonoids; Gas Chromatography-Mass Spectrometry; Gene Expression; Humans; I-kappa B Kinase; Inflammation; Interleukin-6; Interleukin-8; Mast Cells; NF-kappa B; Plant Extracts; Plants, Medicinal; Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2010 |